185 related items for PubMed ID: 10603129
21. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.
Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WC, Wetzels JF, van der Heijden AJ, Nauta J.
J Am Soc Nephrol; 2013 Jan; 24(1):149-59. PubMed ID: 23274956
[Abstract] [Full Text] [Related]
22. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
Sheikh S, Mishra K, Kumar M.
Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
[Abstract] [Full Text] [Related]
23. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
24. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P, Jesdapatarakul S.
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[Abstract] [Full Text] [Related]
25. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A.
Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
[Abstract] [Full Text] [Related]
26. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
27. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK, Bagga A, Srivastava RN.
Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
[Abstract] [Full Text] [Related]
28. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
[Abstract] [Full Text] [Related]
29. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome.
Mattoo TK, Mahmoud MA.
Nephron; 2000 Aug; 85(4):343-5. PubMed ID: 10940745
[Abstract] [Full Text] [Related]
30. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
31. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.
Wingen AM, Müller-Wiefel DE, Schärer K.
Clin Nephrol; 1985 Jan; 23(1):35-40. PubMed ID: 3978880
[Abstract] [Full Text] [Related]
32. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
33. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T.
J Pediatr; 1988 Jan; 112(1):122-6. PubMed ID: 3335948
[Abstract] [Full Text] [Related]
34. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
[Abstract] [Full Text] [Related]
35. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
[Abstract] [Full Text] [Related]
36. Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis.
Schijvens AM, Teeninga N, Dorresteijn EM, Teerenstra S, Webb NJ, Schreuder MF.
Eur J Pediatr; 2021 Sep 27; 180(9):2849-2859. PubMed ID: 33774744
[Abstract] [Full Text] [Related]
37. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children.
J Pediatr; 1979 Aug 27; 95(2):239-43. PubMed ID: 109598
[Abstract] [Full Text] [Related]
38. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
Int J Pediatr Nephrol; 1985 Aug 27; 6(4):245-50. PubMed ID: 4093243
[Abstract] [Full Text] [Related]
39. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
Turk J Pediatr; 1999 Aug 27; 41(2):225-30. PubMed ID: 10770662
[Abstract] [Full Text] [Related]
40. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
